A herceptin-targeted PAMAM G4 dendrimer functionalized with diglycolamic acid (DGA) was also used as a drug carrier for cisplatin in human ovarian cancer HER-2+ and HER-2− [33]. Here, ERBB2 is linked to ovarian carcinoma.